View Archive »
About The Cover
The cover for issue 69 of Oncotarget features Figure 3B, "The Ewing sarcoma cell lines TC-71 and CADO-ES1 are competent for homologous recombination repair," from Vormoor, et al.
|
|
Table of Contents
Research Papers
|
| TLR signaling inhibitor phenylmethimazole in combination with tamoxifen inhibits human breast cancer cell viability and migration |
|
https://doi.org/10.18632/oncotarget.10358
|
| 113295-113302 |
|
| The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease |
|
https://doi.org/10.18632/oncotarget.22964
|
| 113303-113317 |
|
| Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection |
|
https://doi.org/10.18632/oncotarget.22966
|
| 113318-113330 |
|
| MAEL contributes to gastric cancer progression by promoting ILKAP degradation |
|
https://doi.org/10.18632/oncotarget.22970
|
| 113331-113344 |
|
| Expansion of tumorinfiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer |
|
https://doi.org/10.18632/oncotarget.23007
|
| 113345-113359 |
|
| The IL17BIL17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway |
|
https://doi.org/10.18632/oncotarget.23008
|
| 113360-113372 |
|
| Cellsurface marker discovery for lung cancer |
|
https://doi.org/10.18632/oncotarget.23009
|
| 113373-113402 |
|
| Longterm administration of tacrolimus and everolimus prevents high cholesterolhigh fructoseinduced steatosis in C57BL/6J mice by inhibiting denovo lipogenesis |
|
https://doi.org/10.18632/oncotarget.15194
|
| 113403-113417 |
|
| Sensitizing Ewing sarcoma to chemo and radiotherapy by inhibition of the DNArepair enzymes DNA protein kinase DNAPK and polyADPribose polymerase PARP 1/2 |
|
https://doi.org/10.18632/oncotarget.21300
|
| 113418-113430 |
|
| Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.22266
|
| 113431-113443 |
|
| Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients |
|
https://doi.org/10.18632/oncotarget.23049
|
| 113444-113459 |
|
| Helicobacter pylori CagA protein activates Akt and attenuates chemotherapeuticsinduced apoptosis in gastric cancer cells |
|
https://doi.org/10.18632/oncotarget.23050
|
| 113460-113471 |
|
| Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib |
|
https://doi.org/10.18632/oncotarget.23052
|
| 113472-113493 |
|
| PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2positive gastric cancer |
|
https://doi.org/10.18632/oncotarget.23054
|
| 113494-113501 |
|
| The glucose and lipid metabolism reprogramming is gradedependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation |
|
https://doi.org/10.18632/oncotarget.23056
|
| 113502-113515 |
|
| A natural inhibitor of kidneytype glutaminase: a withanolide from Physalis pubescens with potent antitumor activity |
|
https://doi.org/10.18632/oncotarget.23058
|
| 113516-113530 |
|
| Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dosedense and docetaxelcontaining adjuvant chemotherapy |
|
https://doi.org/10.18632/oncotarget.22697
|
| 113531-113542 |
|
| Differentially expressed mRNAs lncRNAs and miRNAs with associated coexpression and ceRNA networks in ankylosing spondylitis |
|
https://doi.org/10.18632/oncotarget.22708
|
| 113543-113557 |
|
| miR7695p suppressed cell proliferation migration and invasion by targeting TGFBR1 in nonsmall cell lung carcinoma |
|
https://doi.org/10.18632/oncotarget.23060
|
| 113558-113570 |
|
| Identification and comparison of novel circular RNAs with associated coexpression and competing endogenous RNA networks in pulmonary tuberculosis |
|
https://doi.org/10.18632/oncotarget.22710
|
| 113571-113582 |
|
| Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6 NEDD9 and MT1MMP |
|
https://doi.org/10.18632/oncotarget.22745
|
| 113583-113597 |
|
| Identification of novel genes in aging osteoblasts using nextgeneration sequencing and bioinformatics |
|
https://doi.org/10.18632/oncotarget.22748
|
| 113598-113613 |
|
| Induction of oxidative stress and cell apoptosis by selenium: the cure against oral carcinoma |
|
https://doi.org/10.18632/oncotarget.22752
|
| 113614-113621 |
|
| Long noncoding RNA Lucat1 is a poor prognostic factor and demonstrates malignant biological behavior in clear cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.21185
|
| 113622-113634 |
|
| Ubiquitin carboxylterminal hydrolase isozyme L5 inhibits human glioma cell migration and invasion via downregulating SNRPF |
|
https://doi.org/10.18632/oncotarget.23071
|
| 113635-113649 |
|
| LncRNA TUG1 sponges miR145 to promote cancer progression and regulate glutamine metabolism via Sirt3/GDH axis |
|
https://doi.org/10.18632/oncotarget.21922
|
| 113650-113661 |
|
| Molecular targeting of cellpermeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation |
|
https://doi.org/10.18632/oncotarget.21939
|
| 113662-113672 |
|
| Largescale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma |
|
https://doi.org/10.18632/oncotarget.22817
|
| 113673-113686 |
|
| Elucidating respective functions of two domains BIR and Chelix of human IAP survivin for precise targeted regulating mitotic cycle apoptosis and autophagy of cancer cells |
|
https://doi.org/10.18632/oncotarget.22823
|
| 113687-113700 |
|
| The lncRNA XIST interacts with miR140/miR124/iASPP axis to promote pancreatic carcinoma growth |
|
https://doi.org/10.18632/oncotarget.22555
|
| 113701-113718 |
|
| Doxorubicinfucoidangold nanoparticles composite for dualchemophotothermal treatment on eye tumors |
|
https://doi.org/10.18632/oncotarget.23092
|
| 113719-113733 |
|
| Dietary quercetin potentiates the antiproliferative effect of interferonα in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase |
|
https://doi.org/10.18632/oncotarget.22556
|
| 113734-113748 |
|
| Tumorablative conditioning regimen for haploidentical stem cell transplantation in 102 children with hematologic malignancies: a singlecenter experience |
|
https://doi.org/10.18632/oncotarget.22893
|
| 113749-113757 |
|
| Measurement of tumor volume is not superior to diameter for prediction of lymph node metastasis in early gastric cancer with minute submucosal invasion |
|
https://doi.org/10.18632/oncotarget.22894
|
| 113758-113765 |
|
| BICD1 expression as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas |
|
https://doi.org/10.18632/oncotarget.22667
|
| 113766-113791 |
|
| Episodelike pulse testosterone supplementation induces tumor senescence and growth arrest downmodulating androgen receptor through modulation of pERK1/2 pARser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy |
|
https://doi.org/10.18632/oncotarget.22776
|
| 113792-113806 |
|
| Programmed deathligand 1 expression according to epidermal growth factor receptor mutation status in pretreated nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.22837
|
| 113807-113816 |
|
| Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection |
|
https://doi.org/10.18632/oncotarget.22852
|
| 113817-113827 |
|
| Cell activity during peripheral nerve defect repair process using a nerve scaffold |
|
https://doi.org/10.18632/oncotarget.22978
|
| 113828-113836 |
|
| Overexpression of miR489 enhances efficacy of 5fluorouracilbased treatment in breast cancer stem cells by targeting XIAP |
|
https://doi.org/10.18632/oncotarget.22985
|
| 113837-113846 |
|
| LKB1 loss cooperating with BRAF V600E promotes melanoma cell invasion and migration by upregulation MMP2 via PI3K/Akt/mTOR pathway |
|
https://doi.org/10.18632/oncotarget.22943
|
| 113847-113857 |
|
| Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.23017
|
| 113858-113873 |
|
| Evaluation of the combination of the dual mTORC1/2 inhibitor vistusertib AZD2014 and paclitaxel in ovarian cancer models |
|
https://doi.org/10.18632/oncotarget.23022
|
| 113874-113884 |
|
| Integrated hepatic transcriptional and serum metabolic studies on circulating nutrient metabolism in diurnal laying hens |
|
https://doi.org/10.18632/oncotarget.23032
|
| 113885-113894 |
|
| A comparative global phosphoproteomics analysis of obinutuzumab GA101 versus rituximab RTX against RTX sensitive and resistant Burkitt lymphoma BL demonstrates differential phosphorylation of signaling pathway proteins after treatment |
|
https://doi.org/10.18632/oncotarget.23040
|
| 113895-113909 |
|
| Canine distemper viral infection threatens the giant panda population in China |
|
https://doi.org/10.18632/oncotarget.23042
|
| 113910-113919 |
|
| AntiMüllerian hormone levels in patients with gestational trophoblastic neoplasia treated with different chemotherapy regimens: a prospective cohort study |
|
https://doi.org/10.18632/oncotarget.23027
|
| 113920-113927 |
|
| Gestational diabetes mellitus is associated with decreased adipose and placenta peroxisome proliferatoractivator receptor γ expression in a Chinese population |
|
https://doi.org/10.18632/oncotarget.23043
|
| 113928-113937 |
|
| Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumorbearing c26 mice |
|
https://doi.org/10.18632/oncotarget.23044
|
| 113938-113956 |
|
| Modulation of inflammation by tolllike receptor 4/nuclear factorkappa B in diarrheapredominant irritable bowel syndrome |
|
https://doi.org/10.18632/oncotarget.23045
|
| 113957-113965 |
|
| Knockin human GDF5 proregion L373R mutation as a mouse model for proximal symphalangism |
|
https://doi.org/10.18632/oncotarget.23047
|
| 113966-113976 |
|
| Overexpression of NR4A1 is associated with tumor recurrence and poor survival in nonsmallcell lung carcinoma |
|
https://doi.org/10.18632/oncotarget.23048
|
| 113977-113986 |
|
| Genomewide analysis of the human malaria parasite Plasmodium falciparum transcription factor PfNFYB shows interaction with a CCAAT motif |
|
https://doi.org/10.18632/oncotarget.23053
|
| 113987-114001 |
|
| Factor inhibiting HIF1–A novel target of SUMOylation in the human placenta |
|
https://doi.org/10.18632/oncotarget.23113
|
| 114002-114018 |
|
| A link between RelB expression and tumor progression in laryngeal cancer |
|
https://doi.org/10.18632/oncotarget.23109
|
| 114019-114030 |
|
| Highly preserved consensus gene modules in human papilloma virus 16 positive cervical cancer and head and neck cancers |
|
https://doi.org/10.18632/oncotarget.23116
|
| 114031-114040 |
|
| Prognostic values of long noncoding RNA MIR22HG for patients with hepatocellular carcinoma after hepatectomy |
|
https://doi.org/10.18632/oncotarget.23110
|
| 114041-114049 |
|
| AMRI59 functions as a radiosensitizer via peroxiredoxin Itargeted ROS accumulation and apoptotic cell death induction |
|
https://doi.org/10.18632/oncotarget.23114
|
| 114050-114064 |
|
| MiR124 acts as a target for Alzheimer’s disease by regulating BACE1 |
|
https://doi.org/10.18632/oncotarget.23119
|
| 114065-114071 |
|
| MicroRNA miR147b promotes tumor growth via targeting UBE2N in hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.23120
|
| 114072-114080 |
|
| Association between the PINX1 and NAT2 polymorphisms and serum lipid levels |
|
https://doi.org/10.18632/oncotarget.23123
|
| 114081-114094 |
|
| CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model |
|
https://doi.org/10.18632/oncotarget.23125
|
| 114095-114108 |
|
| 17βEstradiol induces spreading depression and pain behavior in alert female rats |
|
https://doi.org/10.18632/oncotarget.23141
|
| 114109-114122 |
|
| Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicininduced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway |
|
https://doi.org/10.18632/oncotarget.23166
|
| 114123-114135 |
|
| The role of prospero homeobox 1 PROX1 expression in follicular thyroid carcinoma cells |
|
https://doi.org/10.18632/oncotarget.23167
|
| 114136-114155 |
|
| HDAC inhibition potentiates immunotherapy in triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.23169
|
| 114156-114172 |
|
| Insulin and novel thioglycosides exert suppressive effect on human breast and colon carcinoma cells |
|
https://doi.org/10.18632/oncotarget.23170
|
| 114173-114182 |
|
| Identification and validation of colorectal neoplasiaspecific methylation biomarkers based on CTCFbinding sites |
|
https://doi.org/10.18632/oncotarget.23172
|
| 114183-114194 |
|
| ETV4 collaborates with Wnt/βcatenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor |
|
https://doi.org/10.18632/oncotarget.23173
|
| 114195-114209 |
|
| Personalized therapy: CNS HGNETBCOR responsiveness to arsenic trioxide combined with radiotherapy |
|
https://doi.org/10.18632/oncotarget.23174
|
| 114210-114225 |
|
| Suppressor of fused Sufu promotes epithelialmesenchymal transition EMT in cervical squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.23176
|
| 114226-114238 |
|
| Biomarkers identification by a combined clinical and metabonomics analysis in HenochSchonlein purpura nephritis children |
|
https://doi.org/10.18632/oncotarget.23207
|
| 114239-114250 |
|
| Augmentation of hypoxiainducible factor1alpha in reinfused blood cells enhances diabetic ischemic wound closure in mice |
|
https://doi.org/10.18632/oncotarget.23214
|
| 114251-114258 |
|
| Clinical significances and features of prompt brain CT scan after intracranial artery stenting: analysis of 501 cases |
|
https://doi.org/10.18632/oncotarget.23216
|
| 114259-114267 |
|
| Relationships between lymphocyte counts and treatmentrelated toxicities and clinical responses in patients with solid tumors treated with PD1 checkpoint inhibitors |
|
https://doi.org/10.18632/oncotarget.23217
|
| 114268-114280 |
|
| MicroRNA424/E2F6 feedback loop modulates cell invasion migration and EMT in endometrial carcinoma |
|
https://doi.org/10.18632/oncotarget.23218
|
| 114281-114291 |
|
| Sequentially administrated of pemetrexed with icotinib/erlotinib in lung adenocarcinoma cell lines in vitro |
|
https://doi.org/10.18632/oncotarget.23224
|
| 114292-114299 |
|
| Sirt6 mRNAincorporated endothelial microparticles EMPs attenuates DM patientderived EMPinduced endothelial dysfunction |
|
https://doi.org/10.18632/oncotarget.23259
|
| 114300-114313 |
|
| Synthesis and characterization of polyphosphazene microspheres incorporating demineralized bone matrix scaffolds controlled release of growth factor for chondrogenesis applications |
|
https://doi.org/10.18632/oncotarget.23304
|
| 114314-114327 |
|
| CDC5L drives FAH expression to promote metabolic reprogramming in melanoma |
|
https://doi.org/10.18632/oncotarget.23107
|
| 114328-114343 |
|
| Association of miR196a2 rs11614913 and miR499 rs3746444 polymorphisms with cancer risk: a metaanalysis |
|
https://doi.org/10.18632/oncotarget.22547
|
| 114344-114359 |
Clinical Research Papers
|
| Prediction of lowrisk breast cancer using quantitative DCEMRI and its pathological basis |
|
https://doi.org/10.18632/oncotarget.22267
|
| 114360-114370 |
Reviews
|
| Genomic alterations of ERBB receptors in cancer: clinical implications |
|
https://doi.org/10.18632/oncotarget.22825
|
| 114371-114392 |
|
| Microglia at center stage: a comprehensive review about the versatile and unique residential macrophages of the central nervous system |
|
https://doi.org/10.18632/oncotarget.23106
|
| 114393-114413 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
